Transcriptional Switch of Dormant Tumors to Fast-Growing Angiogenic Phenotype
The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Abstract
Tumor dormancy has important implications for early detection and treatment of cancer. Lack of experimental models and limited clinical accessibility constitute major obstacles to the molecular characterization of dormant tumors. We have developed models in which human tumors remain dormant for a prolonged period of time (>120 days) until they switch to rapid growth and become strongly angiogenic. These angiogenic tumors retain their ability to grow fast once injected in new mice. We hypothesized that dormant tumors undergo a stable genetic reprogramming during their switch to the fast-growing phenotype. Genome-wide transcriptional analysis was done to dissect the molecular mechanisms underlying the switch of dormant breast carcinoma, glioblastoma, osteosarcoma, and liposarcoma tumors. A consensus expression signature distinguishing all four dormant versus switched fast-growing tumors was generated. In alignment with our phenotypic observation, the angiogenesis process was the most significantly affected functional gene category. The switch of dormant tumors was associated with down-regulation of angiogenesis inhibitor thrombospondin and decreased sensitivity of angiogenic tumors to angiostatin. The conversion of dormant tumors to exponentially growing tumors was also correlated with regulation and activation of pathways not hitherto linked to tumor dormancy process, such as endothelial cell–specific molecule-1, 5′-ecto-nucleotidase, tissue inhibitor of metalloproteinase-3, epidermal growth factor receptor, insulin-like growth factor receptor, and phosphatidylinositol 3-kinase signaling. Further, novel dormancy-specific biomarkers such as H2BK and Eph receptor A5 (EphA5) were discovered. EphA5 plasma levels in mice and mRNA levels in tumor specimens of glioma patients correlated with diseases stage. These data will be instrumental in identifying novel early cancer biomarkers and could provide a rationale for development of dormancy-promoting tumor therapy strategies. [Cancer Res 2009;69(3):836–44]
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Dormant and active breast cancer cells possess distinct genome-wide expression signature, especially angiogenesis-related genes [96] and our own published work support that resting and active tumor-initiating breast cancer cells respond differently to MSC signals [51].”
From Mesenchymal stem cell secretome and regenerative therapy after cancer (2013) · cites this paper as [96]
In the citing paper
“Importantly, our in vivo mouse model displayed tumor growth kinetics and incidence similar to dormant cancer cell line models [93–96], in contrast to studies relying on aggressive cancer cell lines and resulting often into >100mm3 tumors less than a month after implantation [7].”
From Mesenchymal stem cell secretome and regenerative therapy after cancer (2013) · cites this paper as [96]
Citations
Cites
O'Reilly, M. (1994) · Cell · doi:10.1016/0092-8674(94)90200-3 · Cited by 3,345 · cited 1×
“Angiomotin was found to mediate the antiangiogenic activity of the endogenous angiogenesis inhibitor angiostatin (17, 20), which was shown to suppress tumor growth and maintain dormancy of tumor metastases (21, 22).”
BackgroundSelf-citationHolmgren, L., O'Reilly, M. S., & Folkman, J. (1995) · Nature Medicine · doi:10.1038/nm0295-149 · Cited by 1,878
Self-citationModels, mechanisms and clinical evidence for cancer dormancy
Aguirre-Ghiso, J. A. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2256 · Cited by 1,677
Adaptive immunity maintains occult cancer in an equilibrium state
Koebel, C. M., Vermi, W., Swann, J. B., Zerafa, N., Rodig, S. J., Old, L. J., Smyth, M. J., & Schreiber, R. D. (2007) · Nature · doi:10.1038/nature06309 · Cited by 1,436
TUMOR DORMANCY IN VIVO BY PREVENTION OF NEOVASCULARIZATION
Gimbrone, M. A., Leapman, S. B., Cotran, R. S., & Folkman, J. (1972) · The Journal of Experimental Medicine · doi:10.1084/jem.136.2.261 · Cited by 903
Self-citationHahnfeldt, P., Panigrahy, D., Folkman, J., & Hlatky, L. (1999) · PubMed · Cited by 662
Self-citationAdvances in diagnostic imaging and overestimations of disease prevalence and the benefits of therapy
Black, W. C., & Welch, H. G. (1993) · New England Journal of Medicine · doi:10.1056/nejm199304293281706 · Cited by 547 · cited 1×
“tumor development and are highly prevalent in humans (2).”
BackgroundFolkman, J., & Kalluri, R. (2004) · Nature · doi:10.1038/427787a · Cited by 519 · cited 1×
“It is widely accepted that human tumors can arise in the absence of angiogenic activity and exist in a microscopic dormant state for months to years without neovascularization (1).”
BackgroundSelf-citationRole of insulin-like growth factors and their binding proteins in growth control and carcinogenesis
Grimberg, A., & Cohen, P. (2000) · Journal of Cellular Physiology · doi:10.1002/(sici)1097-4652(200004)183:1<1::aid-jcp1>3.0.co;2-j · Cited by 506 · cited 1×
“The insulin-like growth factor axis has emerged as an important pathway in cancer (28, 29).”
BackgroundA model of human tumor dormancy: an angiogenic switch from the nonangiogenic phenotype
Naumov, G. N., Bender, E., Zurakowski, D., Kang, S.-Y., Sampson, D., Flynn, E., Watnick, R. S., Straume, O., Akslen, L. A., Folkman, J., et al. (2006) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djj068 · Cited by 423 · cited 3×
“cells were prepared and injected to mice as previously described (8, 11).”
BackgroundMethodSelf-citation
Cited by
Metastasis: from dissemination to organ-specific colonization
Nguyen, D. X., Bos, P. D., & Massagué, J. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2622 · Cited by 2,649
“The failure of micrometastatic lesions to trigger the angiogenic switch owing to local anti-angiogenic factors such as thrombospondin has also been associated with dormant metastasi”
BackgroundEph receptors and ephrins in cancer: bidirectional signalling and beyond
Pasquale, E. B. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2806 · Cited by 1,226
“Accordingly, high EPHA5 levels have been detected in various dormant but not fast-growing tumour xenograft model”
BackgroundMechanisms of disseminated cancer cell dormancy: an awakening field
Sosa, M. S., Bragado, P., & Aguirre-Ghiso, J. A. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3793 · Cited by 1,126
The lingering mysteries of metastatic recurrence in breast cancer
Riggio, A. I., Varley, K. E., & Welm, A. L. (2021) · British Journal of Cancer · doi:10.1038/s41416-020-01161-4 · Cited by 616
Brain malignancies: Glioblastoma and brain metastases
Lah, T. T., Novak, M., & Breznik, B. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.10.010 · Cited by 438
Metadata
- Authors
- Almog, N., Ma, L., Raychowdhury, R., Schwager, C., Erber, R., Short, S., Hlatky, L., Vajkoczy, P., Huber, P. E., Folkman, J., & Abdollahi, A.
- Affiliations
- Tufts University (US)
- German Cancer Research Center (DE)
- Charité – Universitätsmedizin Berlin (DE)
- Boston Children's Hospital (US)
- ORCID
- Venue
- Cancer Research
- Published
- 2009-01-29
- Volume
- 69
- Issue
- 3
- Pages
- 836-844
- ISSN
- 0008-5472 (ISSN-L)
- 1538-7445
- OpenAlex
- W2140435181
- Cited by
- 240
- References
- 35
- Citations by year
- 2026: 4 · 2025: 6 · 2024: 2 · 2023: 3 · 2022: 6 · 2021: 17 · 2020: 15 · 2019: 16 · 2018: 15 · 2017: 19 · 2016: 12 · 2015: 12 · 2014: 20 · 2013: 23 · 2012: 23
- FWCI
- 11.58
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Cancer Research (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Physical Sciences › Mathematics › Modeling and Simulation › Mathematical Biology Tumor Growth
- Keywords
- tumor dormancy, tumor angiogenesis, transcriptional reprogramming, thrombospondin, EphA5, tumor markers, breast cancer, glioblastoma, osteosarcoma, liposarcoma, early cancer detection
- MeSH terms
- Angiomotins, Animals, Humans, Male, Membrane Proteins, Microfilament Proteins, Neoplasm Proteins, Neoplasms, Neovascularization, Pathologic, Phenotype, Transcription, Genetic, Tropomyosin, Reproducibility of Results, Polymerase Chain Reaction, Mice, SCID, Gene Expression Profiling, Receptor, EphA5, Intercellular Signaling Peptides and Proteins, Cell Line, Tumor, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Transcriptional Switch of Dormant Tumors to Fast-Growing Angiogenic Phenotype. https://app.cochat.ai/papers/10.1158/0008-5472.can-08-2590
- The paper
- Almog, N., Ma, L., Raychowdhury, R., Schwager, C., Erber, R., Short, S., Hlatky, L., Vajkoczy, P., Huber, P. E., Folkman, J., & Abdollahi, A. (2009). Transcriptional Switch of Dormant Tumors to Fast-Growing Angiogenic Phenotype. Cancer Research. https://doi.org/10.1158/0008-5472.can-08-2590
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.